# Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168

**Authors:** Katia Mancuso, Simona Barbato, Francesco Di Raimondo, Francesca Gay, Pellegrino Musto, Massimo Offidani, Maria Teresa Petrucci, Elena Zamagni, Renato Zambello, Michele Cavo

PMC · DOI: 10.3390/cancers17152555 · Cancers · 2025-08-01

## Full-text entities

- **Diseases:** Multiple Myeloma (MESH:D009101)
- **Chemicals:** Lenalidomide (MESH:D000077269)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12345976/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12345976/full.md

---
Source: https://tomesphere.com/paper/PMC12345976